Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 236
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 
REVIEW ARTICLE
Year : 2015  |  Volume : 4  |  Issue : 3  |  Page : 115-122

A review of pharmaceutical policies in response to economic crises and sanctions


1 Department of Pharmacoeconomics and Pharmaceutical Management, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Health Management and Economics; Department of Global Health and Public Policy, Tehran University of Medical Sciences, Tehran, Iran
3 Department of Pharmacoeconomics and Pharmaceutical Management; Research Center for Pharmaceutical Management and Pharmacoeconomics, Tehran University of Medical Sciences, Tehran, Iran
4 Faculty of Pharmacy, University of Baqiyatallah Medical Sciences, Tehran, Iran

Correspondence Address:
Arash Rashidian
Department of Health Management and Economics; Department of Global Health and Public Policy, Tehran University of Medical Sciences, Tehran
Iran
Login to access the Email id

Source of Support: Nil., Conflict of Interest: There are no conflicts of interest.


DOI: 10.4103/2279-042X.162361

Rights and Permissions

An economic crisis has been defined as a situation in which the scale of a country’s economy becomes smaller in a period of time. Economic crises happen for various reasons, including economic sanctions. Economic crises in a country may affect national priorities for investment and expenditure and reduce available resources, and hence may affect the health care sector including access to medicines. We reviewed the pharmaceutical policies that the countries adopted in order to mitigate the potential negative effects on access to medicines. We reviewed published reports and articles after conducting a comprehensive search of the PubMed and the Google Scholar. After extracting relevant data from the identified articles, we used the World Health Organization (WHO) access to medicines framework as a guide for the categorization of the policies. We identified a total of 40 studies, of which 10 reported the national pharmaceutical policies adopted to reduce the negative impacts of economic crises on access to medicines in high-income and middle-income countries. We identified 89 policies adopted in the 11 countries and categorized them into 12 distinct policy directions. Most of the policies focused on financial aspects of the pharmaceutical sector. In some cases, countries adopted policies that potentially had negative effects on access to medicines. Only Italy had adopted policies encompassing all four accesses to medicine factors recommended by the WHO. While the countries have adopted many seemingly effective policies, little evidence exists on the effectiveness of these policies to improve access to medicines at a time of an economic crisis.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2177    
    Printed47    
    Emailed0    
    PDF Downloaded340    
    Comments [Add]    
    Cited by others 6    

Recommend this journal